132 related articles for article (PubMed ID: 35932401)
1. Serum syndecan-4 correlates with blood pressure and cardiovascular parameters but not proinflammatory markers in healthy older women.
De Luca M; Bryan DR; Hunter GR
Aging Clin Exp Res; 2022 Oct; 34(10):2541-2545. PubMed ID: 35932401
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction.
Ramnath R; Foster RR; Qiu Y; Cope G; Butler MJ; Salmon AH; Mathieson PW; Coward RJ; Welsh GI; Satchell SC
FASEB J; 2014 Nov; 28(11):4686-99. PubMed ID: 25122554
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity.
Bollmann M; Pinno K; Ehnold LI; Märtens N; Märtson A; Pap T; Stärke C; Lohmann CH; Bertrand J
Osteoarthritis Cartilage; 2021 Feb; 29(2):280-289. PubMed ID: 33246160
[TBL] [Abstract][Full Text] [Related]
4. Circulating Levels of the Heparan Sulfate Proteoglycan Syndecan-4 Positively Associate with Blood Pressure in Healthy Premenopausal Women.
De Luca M; Bryan DR; Hunter GR
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668381
[TBL] [Abstract][Full Text] [Related]
5. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
[TBL] [Abstract][Full Text] [Related]
6. Low dose cadmium inhibits syndecan-4 expression in glycocalyx of glomerular endothelial cells.
Meng X; Xie S; Liu J; Lv B; Huang X; Liu Q; Wang X; Malashicheva A; Liu J
J Appl Toxicol; 2024 Jun; 44(6):908-918. PubMed ID: 38396353
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of syndecan-4 upregulation by TNF-α in the endothelium-like EAhy926 cells.
Okuyama E; Suzuki A; Murata M; Ando Y; Kato I; Takagi Y; Takagi A; Murate T; Saito H; Kojima T
J Biochem; 2013 Jul; 154(1):41-50. PubMed ID: 23576453
[TBL] [Abstract][Full Text] [Related]
8. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
9. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.
Wang J; Markova D; Anderson DG; Zheng Z; Shapiro IM; Risbud MV
J Biol Chem; 2011 Nov; 286(46):39738-49. PubMed ID: 21949132
[TBL] [Abstract][Full Text] [Related]
10. Serum syndecan-4 is associated with nonalcoholic fatty liver disease.
Xia SJ; Tang LZ; Li WH; Xu ZS; Zhang LL; Cheng FG; Chen HX; Wang ZH; Luo YC; Dai AN; Fan JG
J Dig Dis; 2021 Sep; 22(9):536-544. PubMed ID: 34374198
[TBL] [Abstract][Full Text] [Related]
11. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
Subramanian SV; Fitzgerald ML; Bernfield M
J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
[TBL] [Abstract][Full Text] [Related]
12. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
[TBL] [Abstract][Full Text] [Related]
13. Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice.
Bertrand J; Stange R; Hidding H; Echtermeyer F; Nalesso G; Godmann L; Timmen M; Bruckner P; Dell'Accio F; Raschke MJ; Pap T; Dreier R
Arthritis Rheum; 2013 Mar; 65(3):743-52. PubMed ID: 23233348
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
Godmann L; Bollmann M; Korb-Pap A; König U; Sherwood J; Beckmann D; Mühlenberg K; Echtermeyer F; Whiteford J; De Rossi G; Pap T; Bertrand J
Ann Rheum Dis; 2020 Apr; 79(4):481-489. PubMed ID: 32094158
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2610-20. PubMed ID: 26193076
[TBL] [Abstract][Full Text] [Related]
16. Genetic Deletion of
De Luca M; Vecchie' D; Athmanathan B; Gopalkrishna S; Valcin JA; Swain TM; Sertie R; Wekesa K; Rowe GC; Bailey SM; Nagareddy PR
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752080
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding.
Zeng Y; Adamson RH; Curry FR; Tarbell JM
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H363-72. PubMed ID: 24285115
[TBL] [Abstract][Full Text] [Related]
18. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease.
Ramnath RD; Butler MJ; Newman G; Desideri S; Russell A; Lay AC; Neal CR; Qiu Y; Fawaz S; Onions KL; Gamez M; Crompton M; Michie C; Finch N; Coward RJ; Welsh GI; Foster RR; Satchell SC
Kidney Int; 2020 May; 97(5):951-965. PubMed ID: 32037077
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline can reduce glycocalyx shedding by inhibiting matrix metalloproteinases in patients undergoing cardiopulmonary bypass: A randomized controlled trial.
Gao W; Fang F; Xia TJ; Zhang Y; Sun J; Wu Q; Wang W
Microvasc Res; 2022 Jul; 142():104381. PubMed ID: 35588887
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
